August 13, 2019
Increasingly, Alzheimer’s disease research has focused on the preclinical stage, when people have biological evidence of Alzheimer’s but either no symptoms or minimal symptoms—the time when interventions might have the potential to prevent future decline of older adults. Harvard Medical School researchers at Massachusetts General Hospital have shed new light on […]